Chlorophyll-derived fatty acids regulate expression of lipid metabolizing enzymes in liver - A nutritional opportunity

OCL - Oleagineux Corps gras Lipides

Volumn 8, Issue 1, 2001, Pages 39-44

  Wolfrum, Christian ^a,b   Spener, Friedrich ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Fatty acid binding protein (FABP); Gene regulation; Peroxisome proliferator activated receptor (PPAR); Phytanic acid; Pristanic acid; oxidation

Indexed keywords

EID: 0035219495     PISSN: 12588210     EISSN: None     Source Type: Journal    
DOI: 10.1051/ocl.2001.0039     Document Type: Article

References (45)

1. BURR GO, BURR MM (1930). On the nature and role of fatty acids essential in nutrition. J Biol Chem, 86: 587-622.
2. SIMOPOULOS AP (1999). Essential fatty acids in health and chronic disease. Am J Clin Nutr, 70: S560-9.
3. RATNAYAKE WM, OLSSON B, ACKMAN RG (1989). Novel branched-chain fatty acids in certain fish oils, Lipids, 24: 630-7.
4. STEINBERG D, VROOM FQ, ENGEL WK, CAMMERMEYER J, MIZE CE, AVIGAN J (1967). Refsum's disease: a recently characterized lipidosis involving the nervous system. Ann Intern Med, 66: 365-95.
5. WOLFRUM C, SPENER F (2000). Fatty acids as regulators of lipid metabolism. Eur J Lipid Sci Technol, 102: 746-62.
6. JUMP DB, CLARKE SD (1999). Regulation of gene expression by dietary fat. Annu Rev Nutr, 19: 63-90.
7. VERHOEVEN NM, WANDERS RJ, POLL-THE BT, SAUDUBRAY JM, JAKOBS C (1998). The metabolism of phytanic acid and pristanic acid in man: a review. J Inherit Metab Dis, 21: 697-728.
8. MOSER HW, BERGIN A, CORNBLATH D (1991). Peroxisomal disorders. Biochem Cell Biol, 69: 463-74.
9. WOLFRUM C, BORRMANN CM, BORCHERS T, SPENER F (2001). Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors α- and γ-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus. Proc Natl Acad Sci USA, 98: 2323-8.
10. PAHAN K, SINGH I (1995). Phytanic acid oxidation: topographical localization of phytanoyl-CoA ligase and transport of phytanic acid into human peroxisomes. J Lipid Res, 36: 986-97.
11. VAN VELDHOVEN PP, MANNAERTS GP, CASTEELS M, CROES K (1999). Hepatic alpha-oxidation of phytanic acid: a revised pathway. Adv Exp Med Biol, 466: 273-81.
12. HASHIMOTO T (1999). Peroxisomal β-oxidation enzymes. Neurochem Res, 24: 551-63.
13. WATKINS PA, CHEN WW, HARRIS CJ, HOEFLER G, HOEFLER S, BLAKE DC Jr, BALFE A, KELLEY RI, MOSER AB, BEARD ME (1989). Peroxisomal bifunctional enzyme deficiency. J Clin Invest, 83: 771-7.
14. WOUTERS FS, BASTIAENS PI, WIRTZ KW, JOVIN TM (1998). FRET microscopy demonstrates molecular association of non-specific lipid transfer protein (nsL-TP) with fatty acid oxidation enzymes in peroxisomes. EMBO J, 17: 7179-89.
15. SEEDORF U, RAABE M, ELLINGHAUS P, KANNENBERG F, FOBKER M, ENGEL T, DENIS S, et al. (1998). Defective peroxisomal catabolism of branched fatty acyl coenzyme A in mice lacking the sterol carrier protein-2/sterol carrier protein-x gene function. Genes Dev, 12: 1189-201.
16. ISSEMANN I, GREEN S (1991). Cloning of novel members of the steroid hormone receptor super-family. J Steroid Biochem Mol Biol, 40: 263-9.
17. LEMBERGER T, DESVERGNE B, WAHLI W (1996). Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology. Annu Rev Cell Dev Biol, 12: 335-63.
18. GÖTTLICHER M, DEMOZ A, SVENSSON D, TOLLET P, BERGE RK, GUSTAFSSON JA (1993). Structural and metabolic requirements for activators of the peroxisome proliferator-activated receptor. Biochem Pharmacol, 46: 2177-84.
19. FORMAN BM, CHEN J, EVANS RM (1997). Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci USA, 94: 4312-7.
20. ELLINGHAUS P, WOLFRUM C, ASSMANN G, SPENER F, SEEDORF U (1999). Phytanic acid activates the peroxisome proliferator-activated receptor alpha (PPARα) in sterol carrier protein 2-/ sterol carrier protein x-deficient mice. J Biol Chem, 274: 2766-72.
21. BRAISSANT O, WAHLI W (1998). Differential expression of peroxisome proliferator-activated receptor-alpha, -beta, and -gamma during rat embryonic development. Endocrinology, 139: 2748-54.
22. KLIEWER SA, FORMAN BM, BLUMBERG B, ONG ES, BORGMEYER U, MANGELSDORF DJ, UMESONO K, EVANS RM (1994). Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA, 91: 7355-9.
23. TONTONOZ P, HU E, GRAVES RA, BUDAVARI AI, SPIEGELMAN BM (1994). mPPAR γ2: tissue-specific regulator of an adipocyte enhancer. Genes Dev, 8: 1224-34.
24. FAJAS L, FRUCHART JC, AUWERX J (1998). PPARγ3 mRNA: a distinct PPARy mRNA subtype transcribed from an independent promoter. FEBS Lett, 438: 55-60.
25. ESCHER P, WAHLI W (2000). Peroxisome proliferator-activated receptors: insight into multiple cellular functions. Mutat Res, 448: 121-38.
26. ELBRECHT A, CHEN Y, CULLINAN CA, HAYES N, LEIBOWITZ M, MOLLER DE, BERGER J (1996). Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2. Biochem Biophys Res Commun, 224: 431-7.
27. HANHOFF T, WOLFRUM C, ELLINGHAUS P, SEEDORF U, SPENER F (2001). Pristanic acid is activator of peroxisome proliferator activated receptor alpha. Eur J Lipid Sci Technol, 103: 75-80.
28. WOLFRUM C, ELLINGHAUS P, FOBKER M, SEEDORF U, ASSMANN G, BÖRCHERS T, SPENER F (1999). Phytanic acid is ligand and transcriptional activator of murine liver fatty acid binding protein. J Lipid Res, 40: 708-14.
29. HOHOFF C, SPENER F (1998). Fatty acid binding proteins and mammary-derived growth inhibitor. Fett/Lipid, 100: 252-63.
30. OCKNER RK, MANNING JA, POPPENHAUSEN RB, HO WK (1972). A binding protein for fatty acids in cytosol of intestinal mucosa, liver, myocardium, and other tissues. Science, 177: 56-8.
31. STORCH J, THUMSER AE (2000). The fatty acid transport function of fatty acid-binding proteins. Biochim Biophys Acta, 1486: 28-44.
32. BÖRCHERS T, HOHOFF C, BUHLMANN C, SPENER F (1997). Heart-type fatty acid binding protein - involvement in growth inhibition and differentiation. Prostaglandins Leukot Essent Fatty Acids, 57: 77-84.
33. VEERKAMP JH, PAULUSSEN RJ, PEETERS RA, MAATMAN RG, VAN MOERKERK HT, VAN KUPPEVELT TH (1990). Detection, tissue distribution and (sub)cellular localization of fatty acid-binding protein types. Mol Cell Biochem, 98: 11-8.
34. BORDEWICK U, HEESE M, BÖRCHERS T, ROBENEK H, SPENER F (1989). Compartmentation of hepatic fatty-acid-binding protein in liver cells and its effect on microsomal phosphatidic acid biosynthesis. Biol Chem Hoppe-Seyler, 370: 229-38.
35. HAUNERLAND N, JAGSCHIES G, SCHULENBERG H, SPENER F (1984). Fatty-acid-binding proteins. Occurrence of two fatty-acid-binding proteins in bovine liver cytosol and their binding of fatty acids, cholesterol, and other lipophilic ligands. Hoppe-Seyler's Z Physiol Chem, 365: 365-76.
36. WOLFRUM C, BÖRCHERS T, SACCHETTINI JC, SPENER F (2000). Binding of fatty acids and peroxisome proliferators to orthologous fatty acid binding proteins from human, murine, and bovine liver. Biochemistry, 39: 1469-74.
37. LIN Q, RUUSKA SE, SHAW NS, DONG D, NOY N (1999). Ligand selectivity of the peroxisome proliferator-activated receptor alpha. Biochemistry, 38: 185-90.
38. WOLFRUM C, BUHLMANN C, ROLF B, BÖRCHERS T, SPENER F (1999). Variation of liver-type fatty acid binding protein content in the human hepatoma cell line HepG2 by peroxisome proliferators and antisense RNA affects the rate of fatty acid uptake. Biochim Biophys Acta, 1437: 194-201.
39. LAWRENCE JW, KROLL DJ, EACHO PI (2000). Ligand-dependent interaction of hepatic fatty acid-binding protein with the nucleus. J Lipid Res, 41: 1390-401.
40. DUTTA-ROY AK (2000). Cellular uptake of long-chain fatty acids: role of membrane-associated fatty-acid-binding/transport proteins. Cell Mol Life Sci, 57: 1360-72.
41. KREY G, MAHFOUDI A, WAHLI W (1995). Functional interactions of peroxisome proliferator-activated receptor, retinoid-X receptor, and Sp1 in the transcriptional regulation of the acylcoenzyme-A oxidase promoter. Mol Endocrinol, 9: 219-31.
42. ISSEMANN I, PRINCE R, TUGWOOD J, GREEN S (1992). A role for fatty acids and liver fatty acid binding protein in peroxisome proliferation? Biochem Soc Trans, 20: 824-7.
43. KAHLKE W, WAGENER H, DIECKMANN H (1965). Studies on the phytol metabolism in lipoidosis heredopathia atactica polyneuritiformis (Refsum's syndrome). The transformation of 3H-phytol into the 3,7,11,15-tetramethylhexadecanoic acid (phytanic acid) of the plasma lipoid fractions. Klin Wochenschr, 43: 1345-7.
44. JANSEN GA, FERDINANDUSSE S, SKJELDAL OH, STOKKE O, DE GROOT CJ, JAKOBS C, WANDERS RJ (1998). Molecular basis of Refsum disease: identification of new mutations in the phytanoyl-CoA hydroxylase cDNA. J Inherit Metab Dis, 21: 288-91.
45. IDEL S, ELLINGHAUS P, WOLFRUM C, NOFER JR, ASSMANN G, SPENER F, SEEDORF U (2001). Dietary branched-chain fatty acids induce apoptosis in vascular smooth muscle cells. J Biol Chem, submitted.